Laura Nollino
Laura Nollino publishes mostly in Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Surgery, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Advanced Glycation End Products research.
- World rank
- #3,395,946 of 7,710,434 ranked researchers
- Rank in Italy
- #115,071 of 242,206
- Works
- 20
- Citations
- 226
- Citations per work
- 11.3
What does Laura Nollino research?
Laura Nollino's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1050.0%
- Medicine1050.0%
- Everything else631.4%
- Life Sciences418.6%
- 1Endocrinology, Diabetes and Metabolism41% of their works
- 2Clinical Biochemistry9% of their works
- 3Surgery6% of their works
- 4Genetics6% of their works
- 5Epidemiology4% of their works
- 6Molecular Biology4% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Advanced Glycation End Products research
- Diabetes Management and Education
- Diabetes and associated disorders
- Metabolism, Diabetes, and Cancer
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Laura Nollino's research?
The keywords of their largest research topics: Glycemic Control, Diabetes, Insulin Therapy, Type 1 Diabetes, Cardiovascular Disease, Cardiovascular Outcomes, Continuous Glucose Monitoring and Hypoglycemia.
- Metabolic Syndrome
- Hyperglycemia
- AMP-Activated Protein Kinase
- Autoimmunity
- Depression
- Advanced Glycation End Products
- Hypoglycemia
- Cardiovascular Outcomes
- Type 1 Diabetes
- Diabetes
- Glycemic Control
- Insulin Therapy
- Cardiovascular Disease
- Continuous Glucose Monitoring
- Type 2 Diabetes
- HMGB1
- Self-Management
- Genetics
- Critical Care
- Insulin Resistance
- Metformin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control184 topics
- Diabetes174 topics
- Insulin Therapy143 topics
- Type 1 Diabetes92 topics
- Cardiovascular Disease82 topics
- Cardiovascular Outcomes61 topic
- Continuous Glucose Monitoring61 topic
- Hypoglycemia61 topic
- Type 2 Diabetes61 topic
- Advanced Glycation End Products51 topic
- HMGB151 topic
- Depression41 topic
- Self-Management41 topic
- Autoimmunity31 topic
- Genetics31 topic
- AMP-Activated Protein Kinase21 topic
- Critical Care21 topic
- Hyperglycemia21 topic
- Insulin Resistance21 topic
- Metabolic Syndrome21 topic
- Metformin21 topic
Where does Laura Nollino work?
Laura Nollino's main affiliation in the publication record is AULSS 2 Marca Trevigiana, Italy.
How many publications and citations does Laura Nollino have?
OpenAlex counts 20 works and 226 citations for Laura Nollino, an h-index of 8, ranking #3,395,946 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Laura Nollino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.